Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore
: Little is currently known concerning the mechanisms responsible for the excessive deposition of redox‐active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non‐transferrin‐deriv...
Gespeichert in:
Veröffentlicht in: | Journal of neurochemistry 1999-05, Vol.72 (5), p.1802-1811 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1811 |
---|---|
container_issue | 5 |
container_start_page | 1802 |
container_title | Journal of neurochemistry |
container_volume | 72 |
creator | Schipper, H. M. Bernier, L. Mehindate, K. Frankel, D. |
description | : Little is currently known concerning the mechanisms responsible for the excessive deposition of redox‐active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non‐transferrin‐derived iron by the mitochondrial compartment of cultured rat astroglia and that the mechanism underlying this novel dopamine effect is oxidative in nature. We also provide evidence that up‐regulation of the stress protein heme oxygenase‐1 (HO‐1) is both necessary and sufficient for mitochondrial iron trapping in dopamine‐challenged astroglia. Finally, we show that opening of the mitochondrial transition pore (MTP) mediates the influx of non‐transferrin‐derived iron into mitochondria of dopamine‐stimulated and HO‐1‐transfected astroglia. Our findings provide an explanation for the pathological iron sequestration, mitochondrial insufficiency, and amplification of oxidative injury reported in the brains of PD subjects. Pharmacological blockade of transition metal trapping by “stressed” astroglial mitochondria (e.g., using HO‐1 inhibitors or modulators of the MTP) may afford effective neuroprotection in patients with PD and other neurological afflictions. |
doi_str_mv | 10.1046/j.1471-4159.1999.0721802.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17300336</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17300336</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4832-5fe5fbb91e67d2f82c50f2c5402f7b8dfe5248bf0c71c0c309d254ef2fe5958d3</originalsourceid><addsrcrecordid>eNqVkctuEzEUhi0EoqHwCshCiN0Mx557N6gKlxa1tIKytjye48SRZxzsiUh2LHiAPmOfBE8TAdtufNH_nePj_yfkFYOUQV6-XaUsr1iSs6JJWdM0KVSc1cDT7SMy-ys9JjMAzpMMcn5EnoWwAmBlXrKn5IgBZxUvyhn5fWlGp5Zu6LyRlp57N9Bv-GODYfRyNPFmBvrerWVvBrz7dTtfSmtxWGBHTyPiFtbIE_rVWaRO0zPskV5tdwscZJhwRuXQ0XGJ9Bp9j7I11ow7euPlEMx9-2vn8Tl5oqUN-OKwH5PvHz_czM-Si6tP5_PTi0TldcaTQmOh27ZhWFYd1zVXBei45MB11dZdlHletxpUxRSoDJqOFzlqHoWmqLvsmLzZ9117d_9F0Zug0Fo5oNsEwaoMIMvKCJ7sQeVdCB61WHvTS78TDMSUgViJyWgxGS2mDMQhA7GNxS8Pr2zaHrv_SvemR-D1AZBBSaujGcqEf1wNcdwmYu_22E9jcfeACcTnL_PplP0BS7imkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17300336</pqid></control><display><type>article</type><title>Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore</title><source>MEDLINE</source><source>Wiley Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><source>IngentaConnect Free/Open Access Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Schipper, H. M. ; Bernier, L. ; Mehindate, K. ; Frankel, D.</creator><creatorcontrib>Schipper, H. M. ; Bernier, L. ; Mehindate, K. ; Frankel, D.</creatorcontrib><description>: Little is currently known concerning the mechanisms responsible for the excessive deposition of redox‐active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non‐transferrin‐derived iron by the mitochondrial compartment of cultured rat astroglia and that the mechanism underlying this novel dopamine effect is oxidative in nature. We also provide evidence that up‐regulation of the stress protein heme oxygenase‐1 (HO‐1) is both necessary and sufficient for mitochondrial iron trapping in dopamine‐challenged astroglia. Finally, we show that opening of the mitochondrial transition pore (MTP) mediates the influx of non‐transferrin‐derived iron into mitochondria of dopamine‐stimulated and HO‐1‐transfected astroglia. Our findings provide an explanation for the pathological iron sequestration, mitochondrial insufficiency, and amplification of oxidative injury reported in the brains of PD subjects. Pharmacological blockade of transition metal trapping by “stressed” astroglial mitochondria (e.g., using HO‐1 inhibitors or modulators of the MTP) may afford effective neuroprotection in patients with PD and other neurological afflictions.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1046/j.1471-4159.1999.0721802.x</identifier><identifier>PMID: 10217256</identifier><identifier>CODEN: JONRA9</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Astrocyte ; Astrocytes - drug effects ; Astrocytes - metabolism ; Biological and medical sciences ; Cells, Cultured ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Dopamine - pharmacology ; Dopamine Agents - pharmacology ; Heme Oxygenase (Decyclizing) - physiology ; Heme Oxygenase-1 ; Hydrogen Peroxide - pharmacology ; Intracellular Membranes - metabolism ; Iron ; Iron - metabolism ; Levodopa - pharmacology ; Medical sciences ; Mitochondria ; Mitochondria - metabolism ; Neurology ; Norepinephrine - pharmacology ; Oxidants - pharmacology ; Oxidative stress ; Parkinson's disease ; Permeability ; Permeability transition pore ; Rats ; Rats, Sprague-Dawley ; Vitamin K - pharmacology</subject><ispartof>Journal of neurochemistry, 1999-05, Vol.72 (5), p.1802-1811</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4832-5fe5fbb91e67d2f82c50f2c5402f7b8dfe5248bf0c71c0c309d254ef2fe5958d3</citedby><cites>FETCH-LOGICAL-c4832-5fe5fbb91e67d2f82c50f2c5402f7b8dfe5248bf0c71c0c309d254ef2fe5958d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1471-4159.1999.0721802.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1471-4159.1999.0721802.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1805959$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10217256$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schipper, H. M.</creatorcontrib><creatorcontrib>Bernier, L.</creatorcontrib><creatorcontrib>Mehindate, K.</creatorcontrib><creatorcontrib>Frankel, D.</creatorcontrib><title>Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>: Little is currently known concerning the mechanisms responsible for the excessive deposition of redox‐active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non‐transferrin‐derived iron by the mitochondrial compartment of cultured rat astroglia and that the mechanism underlying this novel dopamine effect is oxidative in nature. We also provide evidence that up‐regulation of the stress protein heme oxygenase‐1 (HO‐1) is both necessary and sufficient for mitochondrial iron trapping in dopamine‐challenged astroglia. Finally, we show that opening of the mitochondrial transition pore (MTP) mediates the influx of non‐transferrin‐derived iron into mitochondria of dopamine‐stimulated and HO‐1‐transfected astroglia. Our findings provide an explanation for the pathological iron sequestration, mitochondrial insufficiency, and amplification of oxidative injury reported in the brains of PD subjects. Pharmacological blockade of transition metal trapping by “stressed” astroglial mitochondria (e.g., using HO‐1 inhibitors or modulators of the MTP) may afford effective neuroprotection in patients with PD and other neurological afflictions.</description><subject>Animals</subject><subject>Astrocyte</subject><subject>Astrocytes - drug effects</subject><subject>Astrocytes - metabolism</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Dopamine - pharmacology</subject><subject>Dopamine Agents - pharmacology</subject><subject>Heme Oxygenase (Decyclizing) - physiology</subject><subject>Heme Oxygenase-1</subject><subject>Hydrogen Peroxide - pharmacology</subject><subject>Intracellular Membranes - metabolism</subject><subject>Iron</subject><subject>Iron - metabolism</subject><subject>Levodopa - pharmacology</subject><subject>Medical sciences</subject><subject>Mitochondria</subject><subject>Mitochondria - metabolism</subject><subject>Neurology</subject><subject>Norepinephrine - pharmacology</subject><subject>Oxidants - pharmacology</subject><subject>Oxidative stress</subject><subject>Parkinson's disease</subject><subject>Permeability</subject><subject>Permeability transition pore</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Vitamin K - pharmacology</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkctuEzEUhi0EoqHwCshCiN0Mx557N6gKlxa1tIKytjye48SRZxzsiUh2LHiAPmOfBE8TAdtufNH_nePj_yfkFYOUQV6-XaUsr1iSs6JJWdM0KVSc1cDT7SMy-ys9JjMAzpMMcn5EnoWwAmBlXrKn5IgBZxUvyhn5fWlGp5Zu6LyRlp57N9Bv-GODYfRyNPFmBvrerWVvBrz7dTtfSmtxWGBHTyPiFtbIE_rVWaRO0zPskV5tdwscZJhwRuXQ0XGJ9Bp9j7I11ow7euPlEMx9-2vn8Tl5oqUN-OKwH5PvHz_czM-Si6tP5_PTi0TldcaTQmOh27ZhWFYd1zVXBei45MB11dZdlHletxpUxRSoDJqOFzlqHoWmqLvsmLzZ9117d_9F0Zug0Fo5oNsEwaoMIMvKCJ7sQeVdCB61WHvTS78TDMSUgViJyWgxGS2mDMQhA7GNxS8Pr2zaHrv_SvemR-D1AZBBSaujGcqEf1wNcdwmYu_22E9jcfeACcTnL_PplP0BS7imkA</recordid><startdate>199905</startdate><enddate>199905</enddate><creator>Schipper, H. M.</creator><creator>Bernier, L.</creator><creator>Mehindate, K.</creator><creator>Frankel, D.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>199905</creationdate><title>Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore</title><author>Schipper, H. M. ; Bernier, L. ; Mehindate, K. ; Frankel, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4832-5fe5fbb91e67d2f82c50f2c5402f7b8dfe5248bf0c71c0c309d254ef2fe5958d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Astrocyte</topic><topic>Astrocytes - drug effects</topic><topic>Astrocytes - metabolism</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Dopamine - pharmacology</topic><topic>Dopamine Agents - pharmacology</topic><topic>Heme Oxygenase (Decyclizing) - physiology</topic><topic>Heme Oxygenase-1</topic><topic>Hydrogen Peroxide - pharmacology</topic><topic>Intracellular Membranes - metabolism</topic><topic>Iron</topic><topic>Iron - metabolism</topic><topic>Levodopa - pharmacology</topic><topic>Medical sciences</topic><topic>Mitochondria</topic><topic>Mitochondria - metabolism</topic><topic>Neurology</topic><topic>Norepinephrine - pharmacology</topic><topic>Oxidants - pharmacology</topic><topic>Oxidative stress</topic><topic>Parkinson's disease</topic><topic>Permeability</topic><topic>Permeability transition pore</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Vitamin K - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schipper, H. M.</creatorcontrib><creatorcontrib>Bernier, L.</creatorcontrib><creatorcontrib>Mehindate, K.</creatorcontrib><creatorcontrib>Frankel, D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schipper, H. M.</au><au>Bernier, L.</au><au>Mehindate, K.</au><au>Frankel, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>1999-05</date><risdate>1999</risdate><volume>72</volume><issue>5</issue><spage>1802</spage><epage>1811</epage><pages>1802-1811</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><coden>JONRA9</coden><abstract>: Little is currently known concerning the mechanisms responsible for the excessive deposition of redox‐active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non‐transferrin‐derived iron by the mitochondrial compartment of cultured rat astroglia and that the mechanism underlying this novel dopamine effect is oxidative in nature. We also provide evidence that up‐regulation of the stress protein heme oxygenase‐1 (HO‐1) is both necessary and sufficient for mitochondrial iron trapping in dopamine‐challenged astroglia. Finally, we show that opening of the mitochondrial transition pore (MTP) mediates the influx of non‐transferrin‐derived iron into mitochondria of dopamine‐stimulated and HO‐1‐transfected astroglia. Our findings provide an explanation for the pathological iron sequestration, mitochondrial insufficiency, and amplification of oxidative injury reported in the brains of PD subjects. Pharmacological blockade of transition metal trapping by “stressed” astroglial mitochondria (e.g., using HO‐1 inhibitors or modulators of the MTP) may afford effective neuroprotection in patients with PD and other neurological afflictions.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>10217256</pmid><doi>10.1046/j.1471-4159.1999.0721802.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3042 |
ispartof | Journal of neurochemistry, 1999-05, Vol.72 (5), p.1802-1811 |
issn | 0022-3042 1471-4159 |
language | eng |
recordid | cdi_proquest_miscellaneous_17300336 |
source | MEDLINE; Wiley Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content; IngentaConnect Free/Open Access Journals; Free Full-Text Journals in Chemistry |
subjects | Animals Astrocyte Astrocytes - drug effects Astrocytes - metabolism Biological and medical sciences Cells, Cultured Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Dopamine - pharmacology Dopamine Agents - pharmacology Heme Oxygenase (Decyclizing) - physiology Heme Oxygenase-1 Hydrogen Peroxide - pharmacology Intracellular Membranes - metabolism Iron Iron - metabolism Levodopa - pharmacology Medical sciences Mitochondria Mitochondria - metabolism Neurology Norepinephrine - pharmacology Oxidants - pharmacology Oxidative stress Parkinson's disease Permeability Permeability transition pore Rats Rats, Sprague-Dawley Vitamin K - pharmacology |
title | Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A01%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrial%20Iron%20Sequestration%20in%20Dopamine%E2%80%90Challenged%20Astroglia:%20Role%20of%20Heme%20Oxygenase%E2%80%901%20and%20the%20Permeability%20Transition%20Pore&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Schipper,%20H.%20M.&rft.date=1999-05&rft.volume=72&rft.issue=5&rft.spage=1802&rft.epage=1811&rft.pages=1802-1811&rft.issn=0022-3042&rft.eissn=1471-4159&rft.coden=JONRA9&rft_id=info:doi/10.1046/j.1471-4159.1999.0721802.x&rft_dat=%3Cproquest_cross%3E17300336%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17300336&rft_id=info:pmid/10217256&rfr_iscdi=true |